Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Pfizer similarly has all of its non-US production situated inside the bloc....
...This is particularly true in the case of messenger RNA vaccines, such as those made by Moderna and Pfizer, which use genetic code made by a biological process and involve technology that is not easily replicated...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...While bank lending is still expensive, the bond markets are open and companies with investment-grade ratings such as Pfizer, which this year bought Wyeth for $68bn , chose to tap investors directly....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...The call by the Donaldson group – whose members include representatives from oil groups Shell and Chevron, Wall Street banks Goldman Sachs and Morgan Stanley, and drugmaker Pfizer – highlights growing concerns...
...committee’s agenda, companies that have long been in Mr Waxman’s sight, from government contractors such as Halliburton to oil companies such as ExxonMobil and BP, and pharmaceutical companies such as Pfizer...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Blackstone said these and other investments committed to BCP V, the name of the new fund, had a total enterprise value of about $30bn....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition